Company’s 36-month beta value is 0.67.Analysts have differing opinions on the stock, with 7 analysts rating it as a “buy,” 0 as “overweight,” 9 as “hold,” and 1 as “sell.”
The public float for STAA is 49.02M, and currently, short sellers hold a 8.87% ratio of that floaft. The average trading volume of STAA on February 27, 2025 was 868.29K shares.
STAA) stock’s latest price update
The stock price of Staar Surgical Co (NASDAQ: STAA) has dropped by -5.56 compared to previous close of 17.09. Despite this, the company has seen a fall of -4.21% in its stock price over the last five trading days. accessnewswire.com reported 2025-02-27 that NEW YORK, NY / ACCESS Newswire / February 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of STAAR Surgical Company (“STAAR Surgical Company”) (NASDAQ:STAA) concerning possible violations of federal securities laws. Staar reported disappointing earnings for Q4 2024, blaming the results on weak demand in China and a drop in refractive procedures.
STAA’s Market Performance
Staar Surgical Co (STAA) has experienced a -4.21% fall in stock performance for the past week, with a -35.41% drop in the past month, and a -39.51% drop in the past quarter. The volatility ratio for the week is 5.92%, and the volatility levels for the past 30 days are at 6.60% for STAA.. The simple moving average for the past 20 days is -17.15% for STAA’s stock, with a -49.91% simple moving average for the past 200 days.
Analysts’ Opinion of STAA
Mizuho, on the other hand, stated in their research note that they expect to see STAA reach a price target of $17, previously predicting the price at $45. The rating they have provided for STAA stocks is “Neutral” according to the report published on February 12th, 2025.
STAA Trading at -26.93% from the 50-Day Moving Average
After a stumble in the market that brought STAA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -69.36% of loss for the given period.
Volatility was left at 6.60%, however, over the last 30 days, the volatility rate increased by 5.92%, as shares sank -32.31% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -35.51% lower at present.
During the last 5 trading sessions, STAA fell by -2.82%, which changed the moving average for the period of 200-days by -61.79% in comparison to the 20-day moving average, which settled at $19.49. In addition, Staar Surgical Co saw -33.55% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at STAA starting from BROADWOOD PARTNERS, L.P., who purchase 259,616 shares at the price of $14.96 back on Feb 12 ’25. After this action, BROADWOOD PARTNERS, L.P. now owns 11,137,623 shares of Staar Surgical Co, valued at $3,883,255 using the latest closing price.
BROADWOOD PARTNERS, L.P., the 10% Owner of Staar Surgical Co, purchase 115,282 shares at $15.84 during a trade that took place back on Feb 13 ’25, which means that BROADWOOD PARTNERS, L.P. is holding 11,252,905 shares at $1,825,514 based on the most recent closing price.
Stock Fundamentals for STAA
Current profitability levels for the company are sitting at:
- 0.06 for the present operating margin
- 0.78 for the gross margin
The net margin for Staar Surgical Co stands at 0.05. The total capital return value is set at 34.74. Equity return is now at value -5.16, with -4.05 for asset returns.
Based on Staar Surgical Co (STAA), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at 1214.46.
Currently, EBITDA for the company is -5.72 million with net debt to EBITDA at -0.01. When we switch over and look at the enterprise to sales, we see a ratio of 3.01. The receivables turnover for the company is 3401.93for trailing twelve months and the total asset turnover is 520.09. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.23.
Conclusion
In a nutshell, Staar Surgical Co (STAA) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
